Genentech, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 3 867
Quantité totale incluant filiales 3 913 (+ 46 pour les filiales)
Rang # Quantité totale PI 293
Note d'activité PI 4/5.0    2 396
Rang # Activité PI 278
Activité incl filiales 3,7/5.0    2 434
Parent Roche Holding AG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 538 204
452 19
1 631 7
16
 
Dernier brevet 2025 - Adjuvant treatment of her2-posit...
Premier brevet 1978 - Synthetic dna and method therefor
Dernière marque 2024 - IMRASGO
Première marque 1983 - GENENTECH

Filiales

2 subsidiaries with IP (15 patents, 31 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for use in oncology
P/S Pharmaceutical preparations for use in neuroscience
P/S Pharmaceutical preparations for use in immunology
P/S Pharmaceutical preparations for use in oncology, neurology and immunology
P/S Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ...
P/S Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical...
P/S Pharmaceutical preparations for the prevention and treatment of neurological diseases
P/S Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer
P/S Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer.
P/S Pharmaceutical preparations for use in ophthalmology
P/S Pharmaceutical preparations for use in ophthalmology.
Invention Adjuvant treatment of her2-positive breast cancer. Methods are provided for the adjuvant treatme...
P/S Electronic data collection for business purposes in the medical field. Downloadable and recorded ...
Invention Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases. Disclo...
Invention Pharmaceutical asset tracking. Pharmaceutical asset tracking systems and methods for pharmaceuti...
Invention Random heteropolymer excipients for high protein concentration formulations. This application re...
Invention Prevention of disulfide bond reduction during recombinant production of polypeptides. The inventi...
P/S Education, namely providing training in the field of oncology Medical services, namely, providing...
Invention Gene expression markers and treatment of multiple sclerosis. The present invention concerns mark...
Invention Compositions and methods of treating lupus nephritis. The present disclosure provides methods fo...
P/S Ophthalmological apparatus and instruments Education, namely providing training in the field of o...
Invention Guided self-capture of diagnostic images. An app for guided self-capture of images may display a...
P/S Downloadable software in the nature of a mobile application for acting as an information platform...
P/S Pharmaceutical preparations for use in oncology and hematology
Invention Compositions and methods for treating multiple sclerosis. The present invention relates to method...
Invention Anti-ige antibody therapy for multiple food allergies. The present disclosure provides methods a...
Invention Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic informa...
Invention System and method for cell-of-origin classification based on interpretable cellular features. A m...
Invention Inhibitory rna targeting huntingtin expression. The present invention features RNA polynucleotide...
Invention Methods for treatment of cancer with an anti-tigit antagonist antibody. The present invention re...
Invention Multi-vector recombinase mediated cassette exchange. The presently disclosed subject matter rela...
Invention Machine learning enabled region-specific lesion segmentation. A method may include determining, w...
Invention Treatment of multiple myeloma. Provided herein are methods of treatment of cancers, specifically ...
Invention Antibodies and uses thereof. Provided herein are antibodies such as human or humanized antibodie...
Invention In situ detection of barcodes. in situin situ. Advantageously, the method can be effectively used...
Invention Antibodies and uses thereof. Provided herein are antibodies such as human or humanized antibodies...
Invention Clinical formulations of anti-tigit antibodies. The present disclosure relates to pharmaceutical...
Invention Pharmaceutical compound, salts thereof, formulation thereof, and methods of making and using same...
Invention Methods of assessing splice-switching aso features. Provided herein are methods for assessing spl...
Invention Methods of producing tissue-derived epithelial organoids and uses thereof. The present disclosure...
Invention Macrophage signatures for diagnostic and therapeutic methods for lymphoma. The present invention ...
Invention Solid formulations comprising an inhibitor of the k-ras protein having a g12c mutation, and a pro...
Invention Counterfactual generation of molecular conformations. A method may include determining a first c...
Invention Humanized and affinity matured antibodies to fcrh5 and methods of use. The present invention rel...
Invention High-concentration monoclonal antibody formulations. The present application discloses high-conc...
Invention Stabilized il-18 polypeptides and uses thereof. The invention provides stabilized IL-18 polypept...
Invention Spirocyclic cyclic modulators of cholesterol biosynthesis and their use for promoting remyelinati...
Invention Spirocyclic modulators of cholesterol biosynthesis and their use for promoting remyelination. Th...
Invention Spirocyclic bicyclic modulators of cholesterol biosynthesis and their use for promoting remyelina...
Invention Synthetic controls for immunohistochemistry. Provided herein are methods for generating a solid ...
Invention Methods and compositions for classifying and treating kidney cancer. The invention provides meth...
Invention Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-met...
Invention Cell culture compositions with antioxidants and methods for polypeptide production. Cell culture...
Invention Clearance prediction according to antibody property analysis. e.g., etc., etc.) derived from biop...
Invention High-throughput methods for preparing lipid nanoparticles and uses thereof. Provided herein are ...
P/S Pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerativ...
P/S Pharmaceutical ophthalmic preparations
Invention Antibodies and methods of use. The presently disclosed subject matter provides antibodies that b...
Invention Pharmaceutical compositions comprising akt protein kinase inhibitors. The present invention rela...
Invention Therapeutic compounds. The present disclosure relates to compounds and salts thereof that are us...
P/S Scientific laboratory services; providing scientific research information in the field of ophthal...
Invention Novel compositions and methods for the treatment of immune related diseases. The present inventi...
Invention Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors. The present i...
P/S Downloadable computer software for monitoring manufacturing processes in the pharmaceutical industry
2023 P/S Downloadable computer software in the field of health care and medicine, namely for screening and...
P/S Pharmaceutical preparations for the treatment of immune diseases and disorders and inflammatory d...
P/S Downloadable computer software for use in data collection, data processing and database managemen...
Invention Methods of treating tgf beta-related disorders with anti-transforming growth factor beta 3 antibo...
Invention Anti-ige antibody therapy for multiple food allergies. The present disclosure provides methods an...
P/S Downloadable computer software for use in database management in the field of health care and med...
Invention Methods for treatment of liver cancer. The present invention relates to the treatment of liver ca...
2022 Invention Cyclopentylpyrazole cdk2 inhibitors. Described here are compounds of Formula (I) and pharmaceuti...